2007
DOI: 10.1021/nl071114c
|View full text |Cite
|
Sign up to set email alerts
|

Intracellular Delivery of Quantum Dots Tagged Antisense Oligodeoxynucleotides by Functionalized Multiwalled Carbon Nanotubes

Abstract: With the goal of identifying an improved delivery scheme for intracellular tracking and anticancer therapy, we explored a novel double functionalization of a carbon nanotube delivery system containing antisense oligodeoxynucleotides (ASODNs) as a therapeutic gene and CdTe quantum dots as fluorescent labeling probes via electrostatically layer-by-layer assembling. This is the first time that we used mercaptoacetic acid-capped CdTe quantum dots as fluorescent labeling probes for clearly tracking the intracellula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
80
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 148 publications
(83 citation statements)
references
References 40 publications
3
80
0
Order By: Relevance
“…93,94 Jia et al 93 studied double functionalization of an MWCNT delivery system containing ASODNs as a therapeutic gene and semiconductor quantum dots (CdTe) as fluorescent labeling probes (Figure 3). The MWCNT-PEI-ASODNs-CdTe composites showed an ODN delivery efficiency of 95% in human cervical cancer (HeLa) cells and induced much higher cellular apoptosis than PEI-ASODNs or ASODNs alone.…”
Section: Cnts As Odn Carriersmentioning
confidence: 99%
“…93,94 Jia et al 93 studied double functionalization of an MWCNT delivery system containing ASODNs as a therapeutic gene and semiconductor quantum dots (CdTe) as fluorescent labeling probes (Figure 3). The MWCNT-PEI-ASODNs-CdTe composites showed an ODN delivery efficiency of 95% in human cervical cancer (HeLa) cells and induced much higher cellular apoptosis than PEI-ASODNs or ASODNs alone.…”
Section: Cnts As Odn Carriersmentioning
confidence: 99%
“…Pantarotto et al explored the delivery of bioactive peptides of K(FITC)QRMHLRQYELLC into 3T3 cells [12], methotrexate into Jurkat cells [13] and plasmid DNA into HeLa cells [14], using f-CNTs as non-targeted drug carriers. Additionally, f-CNTs have been applied as the non-targeted drug carriers to transport platinum(IV) [15], oligodeoxynucleotides [16] and boron [17] into cancer cells. Although great improvements have been made to the application of f-CNTs as drug carriers, there are two major obstacles blocking further use of the f-CNTs in cancer chemotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, the high surface area along with the tunable surface chemistry enables the physical adsorption or covalent conjugation of a variety of therapeutic molecules, such as drugs, peptides and growth factors [2][3][4][5]. Additionally, NDs' surface can be modified with targeting biological signals to achieve a selective cellular internalization of chemotherapeutic agents as well as genetic materials.…”
mentioning
confidence: 99%